About NextGenHealth.
The science, policy and innovation shaping children’s healthcare, for people who work in and around pharma and biotech.
NextGenHealth covers children’s health and paediatric medicines: new treatments, clinical evidence, drug safety, developments in paediatric conditions and the policy that shapes all of it.
We write for drug developers, regulatory and medical affairs teams, investors, analysts and policy specialists who need to understand how medicines for children are discovered, tested, approved, priced and monitored.
What we cover
- Paediatric Medicines: Formulations, dosing, supply and the business of medicines made for children.
- New Treatments: Pipelines, approvals and first-in-child therapies, from small molecules to gene editing.
- Clinical Evidence: Trial design, data and the evidence base behind paediatric prescribing.
- Drug Safety: Pharmacovigilance, label changes and safety signals in children’s medicines.
- Paediatric Conditions: Developments across the diseases and disorders that affect children.
- Policy: Regulation, incentives, pricing and access across the US, UK and EU.
Contact
Tips, corrections and press releases: editor@nextgen-health.net